 EDEN PRAIRIE, Minn., June 2, 2021 PRNewswire -- NeuroOne Medical Technologies Corporation NASDAQ: NMTC; NeuroOne or the Company, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today the formation of a six member advisory board of leading neurosurgeons to assist in the completion of development of a radio frequency ablation electrode intended to record and ablate brain tissue linked to causing seizure activity. 